- Home
- AMC vs ORIC Comparison
AMC vs ORIC Comparison
Compare AMC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- ORIC
- Stock Information
- Founded
- AMC 1920
- ORIC 2014
- Country
- AMC United States
- ORIC United States
- Employees
- AMC N/A
- ORIC N/A
- Industry
- AMC Movies/Entertainment
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- ORIC Health Care
- Exchange
- AMC Nasdaq
- ORIC Nasdaq
- Market Cap
- AMC 1.3B
- ORIC 1.1B
- IPO Year
- AMC 2013
- ORIC 2020
- Fundamental
- Price
- AMC $2.87
- ORIC $13.70
- Analyst Decision
- AMC Hold
- ORIC Strong Buy
- Analyst Count
- AMC 7
- ORIC 8
- Target Price
- AMC $3.94
- ORIC $16.57
- AVG Volume (30 Days)
- AMC 19.3M
- ORIC 1.7M
- Earning Date
- AMC 11-05-2025
- ORIC 11-11-2025
- Dividend Yield
- AMC N/A
- ORIC N/A
- EPS Growth
- AMC N/A
- ORIC N/A
- EPS
- AMC N/A
- ORIC N/A
- Revenue
- AMC $4,915,600,000.00
- ORIC N/A
- Revenue This Year
- AMC $7.93
- ORIC N/A
- Revenue Next Year
- AMC $6.63
- ORIC N/A
- P/E Ratio
- AMC N/A
- ORIC N/A
- Revenue Growth
- AMC 9.42
- ORIC N/A
- 52 Week Low
- AMC $2.45
- ORIC $3.90
- 52 Week High
- AMC $5.56
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- AMC 47.34
- ORIC 63.42
- Support Level
- AMC $2.82
- ORIC $13.15
- Resistance Level
- AMC $3.00
- ORIC $14.16
- Average True Range (ATR)
- AMC 0.13
- ORIC 0.83
- MACD
- AMC -0.01
- ORIC 0.12
- Stochastic Oscillator
- AMC 17.95
- ORIC 77.58
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.